1. Catalogs
  2. Repligen
  3. XCell ATF® Technology
video corpo

XCell ATF® Technology

XCell ATF® Technology

XCell ATF® Technology

Product catalog summary
Overview
XCell ATF® Technology is designed to enhance upstream processes in biotechnology by increasing cell densities and reducing bioreactor sizes, leading to faster and more efficient production. This technology supports both clinical and commercial manufacturing, optimizing facility utilization and accelerating program advancement.

Key Features
  • High ROI Business Decisions: Reduces bioreactor size by up to 10-fold, from 10,000 L to 1,000 L, allowing for smaller, flexible processes and lower facility expansion costs.
  • Alternating Tangential Flow (ATF): Utilizes alternating flow to extend filter life and enhance robustness, with a self-cleaning mechanism that dislodges film and facilitates backflush.
  • Increased Throughput and Productivity: Enables more programs and molecules per batch, increasing overall capacity and efficiency.

Process Intensification
  • From Process Development to Commercial Scale: Simplifies and accelerates the transition from process development (0.5 L – 50 L) to commercial manufacturing (500 - 5000 L), with increased product yield and reduced costs.
  • Linear Scaling: Provides consistent flow rates from development to commercial scale, supported by ISO 9001:2015 certified manufacturing facilities.

Technical Specifications
  • Device Formats: Available in single-use (SU) and stainless-steel (SS) formats, with chemistry options including Polyethersulfone and Polysulfone.
  • Pore Sizes and Surface Area: Typical pore sizes for SU are 0.2 μ, and for SS are 0.2 µ, 0.5 µ, 50 kDa, with effective surface areas ranging from 0.022 m² to 11 m².
  • Flow Rates: ATF flow ranges from 0.008 - 80 Lpm, with scalable flow/fiber and filtrate rates of 12 mL/min/fiber and 4 - 6 LMH.

Controllers
  • XCell™Lab Controller: Supports XCell ATF® 1, 2, and 4.
  • XCell™ C410 Controller: Supports XCell ATF® 4, 6, and 10.
See more

Catalog excerpts

XCell ATF® Technology   -1

XCell ATF® Technology Data Sheet Intensification delivers more cells, more product, faster. XCell ATF® technology helps develop fast and simple intensified upstream processes that deliver more product, faster. Intensified processes achieve higher cell densities, require smaller bioreactors and consume less suite time. Increase throughput, productivity, and capacity in both clinical and commercial manufacturing towards maximizing your facility utilization, accelerating program advancement and transforming your business decisions. DELIVER MORE, FASTER EXECUTE HIGH ROI BUSINESS DECISIONS Increase throughput: more programs, more molecules Reduce bioreactor size up to 10 fold from 10,000 L to 1,000 L Increase productivity: more product per batch Accelerate your program with smaller, flexible intensified processes Increase capacity: more batches per facility Re-think facility expansion lower cost, lower risk, faster results Alternating flow generates robustness To Bioreactor From Bioreactor  Waste material  Filtrate XCell ATF® technology extends filter lifetime by utilizing the innovative principle of alternating tangential flow. Positive air pressure to a diaphragm pump moves cell culture suspension from the device to the bioreactor in an upstroke while application of a vacuum to the diaphragm moves cell culture suspension from the bioreactor to the device in an opposing down-stroke. In contrast to traditional TFF methods, alternating flow creates a beneficial backflush across the filter surface where filtered media flows from the outside to the inside of the fiber. The reverse flow dislodges film and facilitates filter self-cleaning. Revised 04-01-2021 repligen.com © Repligen Corporation. All rights reserved. All trademarks are the property of their respective

 Open the catalog to page 1
XCell ATF® Technology   -2

Data Sheet XCell ATF® Technology Simplify and fast-track upstream intensification from process development (PD) to commercial scale. The controller and associated low-volume devices generate detailed data for increased process understanding essential for future scale-up. Pilot and process scale systems support robust, linear scale-up studies for manufacturing volumes up to 5000 L with increased product yield in less time. XCell ATF® Systems provide an integrated solution that scales with a consistent flow rate per fiber from PD to commercial scale. Manufactured in an ISO 9001:2015 certified facility,...

 Open the catalog to page 2
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.
About MedicalExpo
MedicalExpo is a marketplace that offers B2B players a complete experience, from product sourcing to purchase. MedicalExpo is an entity of VirtualExpo Group.